Breaking News
October 16, 2018 - New research identifies modifiable dementia risk factor in elderly people
October 16, 2018 - Zebrafish study uncovers molecular ‘brake’ that helps control eye lens development
October 16, 2018 - Overlapping copy number variations underlie autism and schizophrenia in Japanese patients
October 16, 2018 - Majority of Americans’ ancestry can be traced through existing DNA databases
October 16, 2018 - Patients coerced into mental health care less likely to perceive treatment as effective
October 16, 2018 - What you need to know about autism spectrum disorder
October 16, 2018 - Antidepressants can be used to treat Alzheimer’s disease
October 16, 2018 - Study uncovers important role of PRMT1 in dilated cardiomyopathy
October 16, 2018 - Nutritional quality of breakfast linked to cardiovascular and metabolic risk factors in children
October 16, 2018 - Study uses novel approach to investigate genetic origins of mental illnesses
October 16, 2018 - Scientists develop dual anthrax-plague vaccine
October 16, 2018 - Poor Outcomes for Hispanic Infants With Congenital Heart Dz
October 16, 2018 - Global study finds youngest in class more likely to be diagnosed with ADHD
October 16, 2018 - Researchers sequence two selfish genes in the fungus Neurospora intermedia
October 16, 2018 - Survey results highlight the need for better communication between patients and HCPs about bacterial vaginosis
October 16, 2018 - Researchers develop fibrin-targeting immunotherapy to protect against neurodegeneration
October 16, 2018 - Researchers create open access database on healthy immunity
October 16, 2018 - Rice University chemist wins big award to study small surfaces
October 16, 2018 - Study finds 43% drop in stroke rate
October 16, 2018 - Researchers identify basic relationships of cell cycle and cellular senescence in the placenta
October 16, 2018 - UA professor receives NSF grant to develop antifouling materials for medical implants
October 16, 2018 - Obesity Doubles Odds for Colon Cancer in Younger Women
October 16, 2018 - Adults with ADHD not constrained in creativity
October 16, 2018 - Raising visibility for people and students with chronic illness and disability
October 16, 2018 - Allele awarded NIH grant to develop nanoantibody therapies for treatment of sepsis
October 16, 2018 - Only 59% of young adults undergoing surgery are fluid responsive
October 16, 2018 - Research points to potential new treatment for hearing loss
October 16, 2018 - MDI Biological Laboratory receives $1.2 million SEPA grant to promote data literacy
October 16, 2018 - Vast majority of dementia cases may arise from spontaneous genetic errors
October 16, 2018 - New project aims to deliver fast, effective treatment for autoimmune rheumatic diseases
October 16, 2018 - Study identifies molecular switch that controls fate of milk-producing breast cells
October 16, 2018 - Research shows diet has little influence on precursor to gout
October 16, 2018 - “Without Dr. Shumway doing his miracle work, three generations would not be here”: A Stanford heart transplant patient’s story
October 16, 2018 - Non-invasive brain stimulation sheds light on neurobiology underlying implicit bias
October 16, 2018 - Researchers demonstrate integrated technique to control production of cell therapeutics
October 16, 2018 - Breast tomosynthesis detects 34% more tumors than traditional mammography
October 16, 2018 - Rhode Island Hospital, Brown receive $800,000 grant to keep up fight against opioid epidemic
October 16, 2018 - UVA partners with health systems in AVIA network’s Medicaid Transformation Project
October 16, 2018 - Trevena Announces Oliceridine FDA Advisory Committee Meeting Outcome
October 16, 2018 - Study reveals early warning signs of heart problems in patients with newly diagnosed lupus
October 16, 2018 - Connecting the dots of Alzheimer’s disease
October 16, 2018 - New publication offers evidence-based content for global breast imaging medical community
October 16, 2018 - ‘EinsteinVision’ that improves hand-eye coordination of surgeons introduced at Harefield Hospital
October 16, 2018 - WRAIR clinical study evaluates safety and immunogenicity of Marburg vaccine
October 16, 2018 - Ketamine can be considered as alternative to opioids for short-term pain control in ED
October 16, 2018 - Endurance exercise training beneficially alters gut microbiota composition
October 15, 2018 - FDA Approves Yutiq (fluocinolone acetonide intravitreal implant) for Chronic Non-Infectious Posterior Segment Uveitis
October 15, 2018 - Birthing Options for Full-Term Pregnancy
October 15, 2018 - Stressed, toxic, zombie cells seen for first time in Alzheimer’s
October 15, 2018 - Concussion researchers study head motion in high school football hits | News Center
October 15, 2018 - Neuropsychiatric symptoms related to earliest stages of Alzheimer’s brain pathology
October 15, 2018 - Neck collar device may help protect the brain of female high school soccer players
October 15, 2018 - Research reveals how the inner ear processes speech
October 15, 2018 - Many parents still skeptical about safety and effectiveness of flu shot, survey finds
October 15, 2018 - Payer Policies May Discourage Non-Pharma Tx for Low Back Pain
October 15, 2018 - Exercise may delay cognitive decline in people with rare Alzheimer’s disease
October 15, 2018 - Researchers modify CRISPR to reorganize genome | News Center
October 15, 2018 - Innovative brain tumor operation set to tailor to patients’ needs
October 15, 2018 - Findings offer new insight into early changes that occur during AD pathology
October 15, 2018 - Neurons regulating reproductive hormone release have different activity in epileptic mice
October 15, 2018 - More parents are concerned about taking babies swimming in public pools
October 15, 2018 - Health Tip: Know the Risk Factors for Lower Back Pain
October 15, 2018 - Study shows cigarillo flavors enhanced by high-intensity sweeteners
October 15, 2018 - Study traces hospital-acquired bloodstream infections to patients’ own bodies | News Center
October 15, 2018 - Abnormal vision in childhood can affect development of brain areas responsible for attention
October 15, 2018 - Study highlights need for increased support for alcohol-related liver disease patients
October 15, 2018 - Color-changing contact lens could help doctors to monitor eye disease medications
October 15, 2018 - Tobacco heating products cause less staining to teeth than conventional cigarettes
October 15, 2018 - Young adults who are obese can expect to lose up to 10 years in life expectancy
October 15, 2018 - Scientists uncover how proteins meet on the cell membrane
October 15, 2018 - Affordable housing with supportive social services for senior citizens can reduce hospital use
October 15, 2018 - Schiller Easy Pulse Saves Lives
October 15, 2018 - The latest ECG device from Schiller
October 15, 2018 - Following a Tissue Sample
October 15, 2018 - Prisoners need drug and alcohol treatments but AA programs aren’t the answer
October 15, 2018 - Andrea Califano and Jordan Orange Elected to National Academy of Medicine
October 15, 2018 - The impending risk of African Swine Fever Virus
October 15, 2018 - Breastfeeding reduces the number of antibiotic-resistant bacteria in infant gut
October 15, 2018 - Researchers develop comprehensive molecular atlas of postnatal mouse heart development
October 15, 2018 - ObsEva SA Presents Clinical Data from Phase III IMPLANT 2 Trial of Nolasiban in IVF at the American Society of Reproductive Medicine (ASRM) Annual Meeting
Purifying Proteins from Mammalian Cell Culture

Purifying Proteins from Mammalian Cell Culture

image_pdfDownload PDFimage_print

Recombinant proteins can be produced using many types of cells including, yeast, bacteria, insect and mammalian cells. What advantages are there to producing recombinant proteins using mammalian cells over others?

In many cases mammalian cells are the only option to produce recombinant proteins with correct post-translational modifications, e.g. glycosylation, which are required for proper function of the therapeutic protein.

Vshivkova | Shutterstock

E. coli lack the ability to fold complex mammalian proteins and to perform correct post-translational modifications. In addition, the post-translational modifications of yeast and insect cells differ from mammalian cells. Therefore, these host organisms are often a suboptimal option for the production of mammalian proteins, especially if the glycosylation is complex or sialyation is required.

Furthermore, the ability of mammalian cells to secrete proteins into the medium simplifies the downstream process. In contrast to bacteria, mammalian cells can produce large proteins of more than 50 kDa efficiently. Bacterial systems often form inclusion bodies if larger proteins are expressed. In addition, no endotoxins are introduced into the protein sample by the expression procedure.

What are the main applications of recombinant proteins produced in mammalian cells?

Many recombinant proteins produced in mammalian cells are applied for cancer therapy. Especially antibodies and antibody like molecules, which are the most frequently produced proteins.

Membrane proteins are also very important because they are commonly used to study the effects of potential drugs and their mode of operation.

What are the challenges in producing highly pure recombinant proteins for R&D purposes

I think the major challenge is the simultaneous purification of different proteins in a short time with a standard method. Additionally, this method should need no optimization of the purification strategy for different proteins and provide high purities of more than 90%. The purification system must be cost efficient, compatible with many host expression systems and should provide a high flexibility regarding the buffer composition.

Most companies or institutes which must express many different proteins, e.g. during the screening phase of new drug candidates, are facing the same challenges every day. It is worth mentioning that a lot of these proteins are expressed at low levels, especially membrane proteins, making their purification very challenging.

Since different amounts of protein are required for different applications, the purification methods must be easily scalable and should provide a sufficient protein purification capacity.

What is the current standard method to clarify and purify these proteins in your lab? What are the advantages and limitations of this method?

Prior to the Sartoclear Dynamics® Lab method, we used centrifugation for the clarification. First, we pelleted the cells for 10 minutes at 300 g. Then we added a second centrifugation step at 3,000 to 10,000 g to remove cell debris and to prepare the sample for the Strep-Tactin®XT high capacity affinity chromatography purification.

The major drawback of this method is the time needed for the two centrifugation steps. Balancing the tubes, removal of the supernatant, the time for cleaning the centrifugation tubes and the centrifugation time itself can take up to 44 minutes.

Another bottleneck of the current method is the fact that the centrifuge must be available for clarification and since other groups in the lab are using the same machine, this is not always the case.

Finally, the centrifugation process is not very flexible with respect to the sample volume. Our centrifugation tubes must be filled up to at least 80% of the tube volume for higher centrifugation speeds. Therefore, samples below 800 ml must be distributed to several smaller tubes which requires more hands-on time.

Recently you have evaluated a new method of cell clarification and filtration from Sartorius, how does this differ from previous techniques?

The Sartoclear Dynamics® Lab filtration technique improved our clarification process remarkably. In total we were able to reduce the time needed for clarification from 44 minutes down to 12. In addition, because all Sartoclear Dynamics® Lab products are sterile single use, the risk of cross contamination was eliminated, and the filtrate was sterile.

Another aspect is the simplification of the whole process. Since we do not have to rely on a large centrifuge anymore we can conduct the clarification right away in our cell culture lab.

Finally, up and downscaling of the method is quite easy as it is only necessary to adjust the amount of filtration aid.

How were the product quality, protein yield and the IgG aggregation rate affected by using the Sartoclear clarification and filtration method when compared to centrifugation? How was this tested?

Of course, every time you change a method you must ensure that the quality of your product remains unaffected. For us as an ISO 9001 certified company this is absolutely mandatory. To test the influence of the Sartoclear Dynamics® Lab clarification process on the product quality, we clarified a MEXi-293E (HEK293) culture expressing a monoclonal antibody fused to a Twin-Strep-tag®, using our standard centrifugation process in parallel to the Sartoclear Dynamics® Lab method.

After clarification we purified the antibody from the different clarified samples via Strep-Tactin®XT high capacity gravity flow purification. The eluate was analyzed by SDS-PAGE, western blot, photometric measurement at 280 nm and size exclusion chromatography.

The SDS-PAGE and western blot analysis revealed that there was no difference in protein purity between the two clarification methods and that 100% purity was achieved with Strep-Tactin®XT high capacity purification.

The use of Sartoclear Dynamics® Lab did not influence the aggregation of the antibody, because the ratio of aggregated antibody, determined by size exclusion chromatography, was the same as for the centrifuged sample.

Finally, we found that the protein yield was the same for both methods which proved that no antibody was bound to the components of the Sartoclear Dynamics® Lab system.

In summary, the use of the Sartoclear Dynamics® Lab method had no negative effect on protein’s quality or quantity.

In your research, antibodies were labelled with the Twin-Strep-tag® for the purification step. Why do you use this affinity tag system for your purification?

The Strep-tag system allows the purification of proteins under physiological and denaturing conditions with purities usually exceeding 90%. Compared to all other affinity systems the Twin-Strep-tag® in combination with Strep-Tactin®XT reaches the highest binding affinity in pM ranges, while the system still maintains its reversibility. This is advantageous specifically for low concentrated samples in large volumes.

Due to the small size of the Strep-tag®II (8aa) and the Twin-Strep-tag® (28aa) there is no need to remove the tag.

In addition, the system is compatible with a large variety of reagents like detergents, high salt concentrations, reducing agents, chelators, etc.

These properties combined with the fact that the system is suitable for protein purification from bacterial, yeast, insect and mammalian hosts make this system the superior tag system.

It is easy to use without the need for optimization like for example adjusting the imidazole concentration for elution when using His-tag system. This makes the Strep-tag system the perfect solution for the protein purification challenges I have mentioned earlier.

In your research, samples that were centrifuged were not sterile which could be important for many applications and would require a separate sterile filtration step. How would this have been achieved and how would this have affected the procedure used?

We filtered the sample with a 0.2 µm bottle top filter if sterility is required. Of course, this leads to additional process time for clarification and additional costs.

The advantage of the Sartoclear Dynamics® Lab system is that this filtration step is already included in the clarification process.

Therefore, if sterility is required, we do not have to add this step separately.  This increases the time we save by using the Sartoclear Dynamics® Lab system compared to our standard method.

What limitations are there for the Sartoclear method of mammalian cell clarification and filtration?

In our hands, we do not see a limitation on this method. Users should check for the full recovery of their recombinant protein after clarification before using this method regularly, to be on the safe side.

Recombinant proteins have lot of potential in a wide range of applications. What advancements do you hope to see to increase their scalability and widespread use with respect to your R&D applications?

The production of recombinant proteins is still a production in a black box system. Indeed, we have learned a lot about how cells express proteins and which factors can influence protein quantity and quality.

Nevertheless, many aspects of how cells process proteins are still unclear. I think that the improvements in structure analysis, the use of CRISPR/Cas and the great advancements in the field of data analysis and data mining combined with high throughput automatization will lead to more comprehensive knowledge of these intracellular processes. This in return will lead to streamlined protein production processes.

The trend of decreasing the expression scale and increasing the throughput of proteins in an early research and development phase will drive the need for purification systems and formats that support this high throughput processes.

Where can readers find more information?

More information can be found at IBA Life Sciences, Sartorius.

About Dennis Karthaus, MSc

Dennis Karthaus received his master`s degree in biotechnology from the University of Applied Sciences in Bremerhaven. During his thesis at the department of Pharmaceutical Biotechnology at the Fraunhofer Institute for Toxicology and Experimental Medicine he worked on the development of protein purification platforms and in cell line development.

In 2012, Dennis Karthaus joined IBA Lifesciences. He is responsible for the mammalian custom protein expression & purification service and the product development in this field.

Tagged with:

About author

Related Articles